1,831
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

Characterization of recombinant wild-type and nontoxigenic protein A from Staphylococcus pseudintermedius

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1050-1061 | Received 20 Mar 2018, Accepted 05 Jun 2018, Published online: 27 Jul 2018

References

  • Rubin JE, Chirino-Trejo M. Prevalence, sites of colonization, and antimicrobial resistance among Staphylococcus pseudintermedius isolated from healthy dogs in Saskatoon, Canada. J Vet Diagn Invest. 2011 Mar;23(2):351–354. PubMed PMID: 21398462.
  • Bannoehr J, Guardabassi L. Staphylococcus pseudintermedius in the dog: taxonomy, diagnostics, ecology, epidemiology and pathogenicity. Vet Dermatol. 2012 Aug;23(4):253. PubMed PMID: 22515504.
  • van Duijkeren E, Catry B, Greko C, et al. Review on methicillin-resistant Staphylococcus pseudintermedius. J Antimicrob Chemother. 2011 Dec;66(12):2705–2714. PubMed PMID: 21930571.
  • Stegmann R, Burnens A, Maranta CA, et al. Human infection associated with methicillin-resistant Staphylococcus pseudintermedius ST71. J Antimicrob Chemother. 2010 Sep;65(9):2047–2048. PubMed PMID: 20601356.
  • Riegel P, Jesel-Morel L, Laventie B, et al. Coagulase-positive Staphylococcus pseudintermedius from animals causing human endocarditis. Int J Med Microbiol. 2011 Mar;301(3):237–239. PubMed PMID: 21075051.
  • Videla R, Solyman SM, Brahmbhatt A, et al. Clonal complexes and antimicrobial susceptibility profiles of Staphylococcus pseudintermedius isolates from dogs in the United States. Microb Drug Resist. 2017 May 15; PubMed PMID: 28504897. DOI:10.1089/mdr.2016.0250
  • Moodley A, Damborg P, Nielsen SS. Antimicrobial resistance in methicillin susceptible and methicillin resistant Staphylococcus pseudintermedius of canine origin: literature review from 1980 to 2013. Vet Microbiol. 2014 Jul 16;171(3–4):337–341. PubMed PMID: 24613081.
  • Solyman SM, Black CC, Duim B, et al. Multilocus sequence typing for characterization of Staphylococcus pseudintermedius. J Clin Microbiol. 2013 Jan;51(1):306–310. PubMed PMID: 23115265; PubMed Central PMCID: PMCPMC3536184.
  • Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012 Mar 1;18(3):268–281.
  • Thammavongsa V, Kim HK, Missiakas D, et al. Staphylococcal manipulation of host immune responses [Review article]. Nat Rev Microbiol. 2015;13:529–543. .
  • Kim HK, Emolo C, DeDent AC, et al. Protein A-specific monoclonal antibodies and prevention of Staphylococcus aureus disease in mice. Infect Immun. 2012;80(10):3460–3470.
  • Sjoquist J, Movitz J, Johansson IB, et al. Localization of protein A in the bacteria. Eur J Biochem. 1972 Oct 17;30(1):190–194. PubMed PMID: 5086604.
  • Movitz J. Formation of extracellular protein A by Staphylococcus aureus. Eur J Biochem. 1976 Sep;68(1):291–299. PubMed PMID: 964266.
  • Becker S, Frankel MB, Schneewind O, et al. Release of protein A from the cell wall of Staphylococcus aureus. Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):1574–1579. PubMed PMID: 24434550; PubMed Central PMCID: PMCPMC3910568.
  • Schneewind O, Model P, Fischetti VA. Sorting of protein A to the staphylococcal cell wall. Cell. 1992 Jul 24;70(2):267–281. PubMed PMID: 1638631.
  • Lindmark R, Thorén-Tolling K, Sjöquist J. Binding of immunoglobulins to protein A and immunoglobulin levels in mammalian sera. J Immunol Methods. 1983 Jan 1;62(1):1–13.
  • Jensen K. A normally occurring Staphylococcus antibody in human serum. APMIS. 2007 May;115(5):533; discussion 540-1. PubMed PMID: 17504410.
  • Balachandran M, Bemis DA, Kania SA. Expression and function of protein A in Staphylococcus pseudintermedius. Virulence. 2018 Jan 1;9(1):390–401. PubMed PMID: 29157101.
  • Boyle MDP. CHAPTER 1 - Introduction to bacterial immunoglobulin-binding proteins. In Boyle, MDP. editor, Bacterial Immunoglobulin-binding proteins. Cambridge Massachusetts: academic press. 1990. p. 1–21.
  • Sasso EH, Silverman GJ, Mannik M. Human IgM molecules that bind staphylococcal protein A contain VHIII H chains. J Immunol. 1989;142(8):2778–2783.
  • Kim HK, Cheng AG, Kim HY, et al. Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice. J Exp Med. 2010 Aug 30;207(9):1863–1870. PubMed PMID: 20713595; PubMed Central PMCID: PMCPMC2931167.
  • Kim HK, Falugi F, Thomer L, et al. Protein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs. MBio. 2015 Jan 6;6(1):e02369-14. PubMed PMID: 25564466; PubMed Central PMCID: PMCPMC4313907.
  • Pankey JW, Boddie NT, Watts JL, et al. Evaluation of protein A and a commercial bacterin as vaccines against Staphylococcus aureus mastitis by experimental challenge. J Dairy Sci. 1985 Mar 1;68(3):726–731.
  • Dryla A, Prustomersky S, Gelbmann D, et al. Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin Diagn Lab Immunol. 2005;12(3):387–398.
  • Bao Y, Guo Y, Xiao S, et al. Molecular characterization of the VH repertoire in Canis familiaris. Vet Immunol Immunopathol. 2010 Sep 15;137(1–2):64–75. PubMed PMID: 20483487.
  • Pauli NT, Kim HK, Falugi F, et al. Staphylococcus aureus infection induces protein A-mediated immune evasion in humans. J Exp Med. 2014 Nov 17;211(12):2331–2339. PubMed PMID: 25348152; PubMed Central PMCID: PMCPMC4235641.
  • Goodyear CS, Silverman GJ. Death by a B cell superantigen: in vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal Toxin. J Exp Med. 2003 May 5;197(9):1125–1139. PubMed PMID: 12719481; PubMed Central PMCID: PMCPMC2193973.
  • Bannoehr J, Ben Zakour NL, Reglinski M, et al. Genomic and surface proteomic analysis of the canine pathogen Staphylococcus pseudintermedius reveals proteins that mediate adherence to the extracellular matrix. Infect Immun. 2011 Aug;79(8):3074–3086. PubMed PMID: 21576333; PubMed Central PMCID: PMCPMC3147560.
  • Grandolfo E, Looking through Staphylococcus pseudintermedius infections: could SpA be considered a possible vaccine target? Virulence. 2018 Feb 19;1–10. PubMed PMID: 29457988. DOI:10.1080/21505594.2018.1426964
  • Falugi F, Kim HK, Missiakas DM, et al. Role of protein A in the evasion of host adaptive immune responses by Staphylococcus aureus. MBio. 2013 Aug 27;4(5):e00575–13. PubMed PMID: 23982075; PubMed Central PMCID: PMCPMC3760252.
  • Gjertsson I, Hultgren OH, Stenson M, et al. Are B lymphocytes of importance in severe Staphylococcus aureus infections? Infect Immun. 2000;68(5):2431–2434.
  • Hermos CR, Yoong P, Pier GB. High levels of antibody to Panton-Valentine leukocidin are not associated with resistance to Staphylococcus aureus—associated skin and soft-tissue infection. Clin Infect Dis. 2010;51(10):1138–1146.
  • Forsgren A, Nordström K. Protein A from Staphylococcus aureus: the biological significance of its reaction with IgG. Ann N Y Acad Sci. 1974;236:252–266. 19750106 DCOM- 19750106(0077-8923 (Print)). eng.
  • Kearse M, Moir R, Wilson A, et al. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics. 2012 Jun 15;28(12):1647–1649. PubMed PMID: 22543367; PubMed Central PMCID: PMCPMC3371832.
  • Yu NY, Wagner JR, Laird MR, et al. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics. 2010 Jul 1;26(13):1608–1615. PubMed PMID: 20472543; PubMed Central PMCID: PMCPMC2887053.
  • Kelley LA, Mezulis S, Yates CM, et al. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10:845.
  • Wass MN, Kelley LA, Sternberg MJE. 3DLigandSite: predicting ligand-binding sites using similar structures. Nucleic Acids Res. 2010 Jul;38:W469–W473. PubMed PMID: WOS:000284148900076; English.
  • Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry. 1981 Apr 28;20(9):2361–2370. PubMed PMID: 7236608.
  • Gouda H, Shiraishi M, Takahashi H, et al. NMR study of the interaction between the B domain of staphylococcal protein A and the Fc portion of immunoglobulin G. Biochemistry. 1998 Jan 6;37(1):129–136. PubMed PMID: 9425032.
  • Graille M, Stura EA, Corper AL, et al. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc Natl Acad Sci U S A. 2000 May 9;97(10):5399–5404. PubMed PMID: 10805799; PubMed Central PMCID: PMCPMC25840.
  • Riley MC, Perreten V, Bemis DA, et al. Complete genome sequences of three important methicillin-resistant clinical isolates of Staphylococcus pseudintermedius. Genome Announc. 2016 Oct 20;4(5). PubMed PMID: 27795289; PubMed Central PMCID: PMCPMC5073276. DOI:10.1128/genomeA.01194-16
  • Perreten V, Kadlec K, Schwarz S, et al. Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and north America: an international multicentre study. J Antimicrob Chemother. 2010 Jun;65(6):1145–1154. PubMed PMID: 20348087.
  • Kobayashi A, Hirakawa H, Hirata T, et al. Growth phase-dependent expression of drug exporters in Escherichia coli and its contribution to drug tolerance. J Bacteriol. 2006 Feb 9;188(16):5693–5703. /received 05/16/accepted. PubMed PMID: PMC1540079.